Neuroscience NewsInvestigational Anti-amyloid Treatment Started Before Alzheimer’s Symptoms Did Not Slow Memory LossMar 9, 2023more_vert
Investors | Eli Lilly and CompanyLilly Provides Update on A4 Study of Solanezumab for Preclinical Alzheimer's Disease | Eli Lilly and CompanyMar 8, 2023more_vert
CNBCEli Lilly Alzheimer's treatment solanezumab failed to slow disease progressionMar 8, 2023Spencer KimballBy Spencer Kimballmore_vert